The possible mechanism of Li acting on AD may be due to inhibition of glycogen synthase kinase-3 beta (GSK-3β) activity, followed by reducing the hyperphosphorylation of tau and inducing the neuronal death via Aβ overproduction [22]. Here, MAPT is linked to Alzheimer disease.